ADMA in Vascular Disease: More than a Marker?

ADMA in Vascular Disease: More than a Marker?

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2005-10-01
Series:	PLoS Medicine
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240054/?tool=EBI

Similar Items

Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin
by: Avci Emre, et al.
Published: (2020-01-01)

The role of DDAH and ADMA in kidney disease
by: Tomlinson, James
Published: (2013)

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis
by: Laura Dowsett, et al.
Published: (2020-09-01)

Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA.
by: Caroline L Smith, et al.
Published: (2005-10-01)

Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
by: Naveed Sattar, et al.
Published: (2009-06-01)

Analysis of Ghrelin and Asymmetric Dimethylarginine (ADMA) as Endothelial Dysfunction Marker Among Obese Men
by: Lia Meliani, et al.
Published: (2012-08-01)

The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases
by: Nicole Lüneburg, et al.
Published: (2014-01-01)

Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)
by: Jeremy A. Scott, et al.
Published: (2014-04-01)

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
by: Sara Franceschelli, et al.
Published: (2013-12-01)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
by: Dimitrios Tsikas, et al.
Published: (2018-01-01)

Gait variability is affected more by peripheral artery disease than by vascular occlusion.
by: Hafizur Rahman, et al.
Published: (2021-01-01)

Oct-4: More than a Pluripotent Marker?
by: Ketkar Alhad Ashok, et al.
Published: (2009-01-01)

Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction
by: Jana Jankovičová, et al.
Published: (2020-10-01)

Vascular cognitive impairment—prevention is more important than treatment
by: Jian⁃ping JIA, et al.
Published: (2010-06-01)

Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach
by: Elena Oliva-Damaso, et al.
Published: (2019-07-01)

Asymmetric Dimethylarginine (ADMA) level in Serum of Preeclamptic patients
by: Faisal Gh. Al-Rubaye
Published: (2010-01-01)

Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis
by: Maurício Batista Paes Landim, et al.
Published: (2009-05-01)

Bruselloz Hastalarında Asimetrik Dimetilarjinin (ADMA) Düzeylerinin Araştırılması
by: Muhammed Sezgin, et al.
Published: (2019-09-01)

ADMA metabolism and chronic hypoxia-induced pulmonary hypertenstion
by: Iannone, Lucio
Published: (2014)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Does the Inhibitory Action of Asymmetric Dimethylarginine (ADMA) on the Endothelial Nitric Oxide Synthase Activity Explain Its Importance in the Cardiovascular System? The ADMA Paradox
by: Dimitrios Tsikas
Published: (2017-07-01)

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass
by: Johannes Jacobi, et al.
Published: (2014-03-01)

P.036 ADMA – A SENSITIVE MARKER OF ENDOTHELIAL DYSFUNCTION IN CHILDREN WITH FAMILIAR HYPERCHOLESTEROLEMIA AND DIABETES MELLITUS TYPE 1
by: P. Jehlicka*, et al.
Published: (2007-06-01)

From arginine methylation to ADMA: A novel mechanism with therapeutic potential in chronic lung diseases
by: Zakrzewicz Dariusz, et al.
Published: (2009-01-01)

CD56 in the Immune System: More Than a Marker for Cytotoxicity?
by: Heleen H. Van Acker, et al.
Published: (2017-07-01)

Correlation between Nitric oxide (NO) & Asymmetric dimethylargininie (ADMA) Hemoglobin
by: M Kadkhodaei Elyaderani, et al.
Published: (2010-04-01)

CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway
by: Zhen Zhong Zheng, et al.
Published: (2015-12-01)

The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia—Review
by: Weronika Dymara-Konopka, et al.
Published: (2019-06-01)

Roles of the Oxidative Stress and ADMA in the Development of Deep Venous Thrombosis
by: Meral Ekim, et al.
Published: (2014-01-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Effect of Exercise on ADMA Level in Type 2 Diabetes Mellitus
by: Bengur Taşkıran, et al.
Published: (2012-03-01)

ADMA and C-reactive protein as mortality predictors in dialysis patients
by: Ignjatović Aleksandra, et al.
Published: (2013-06-01)

The role of the NOS-ADMA-DDAH1 pathway in adipocytes and obesity
by: Dowsett, Laura Bethany
Published: (2013)

Role of Bilirubin in Diabetic Vascular Complications: Can Bilirubin Predict More than Just Liver Disease?
by: Jun Sung Moon
Published: (2015-10-01)

Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients
by: Rajni Rajendra Shivkar, et al.
Published: (2014-08-01)

Carrion’s disease: more than a neglected disease
by: Meritxell Garcia-Quintanilla, et al.
Published: (2019-03-01)

Neurocysticercosis-more than a neglected disease.
by: Theodore E Nash, et al.
Published: (2013-01-01)

More than a biomarker: could language be a biosocial marker of psychosis?
by: Lena Palaniyappan
Published: (2021-08-01)

Periodontitis is more than a local disease. Epicardial fat tissue amounts to more than an occasional finding
by: Roberto Palma Reis
Published: (2020-12-01)

Periodontitis is more than a local disease. Epicardial fat tissue amounts to more than an occasional finding
by: Roberto Palma Reis
Published: (2020-12-01)